Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ortho Industry Reaches $311 Mil. Settlement With DoJ On Kickback Charges

This article was originally published in The Gray Sheet

Executive Summary

Four major hip and knee implant manufacturers will pay the government a total of $311 million to settle anti-kickback claims resulting from a two-year Department of Justice and HHS investigation into the companies' financial relationships with surgeons, the New Jersey U.S. Attorney's office announced Sept. 27

You may also be interested in...

Medical Device-Makers Face Dynamic Commercial Compliance Risks

Erinn Hutchinson, a Philadelphia-based health industries risk consultant with PricewaterhouseCoopers LLP, talked to Medtech Insight about how she advises medical device companies – big and small – trying to market devices in a dynamic legal compliance environment.

OIG Investigates NuVasive’s Medicare, Medicaid Claims

NuVasive revealed June 30 that it was recently subpoenaed by OIG as part of an investigation into potentially false or improper Medicare and Medicaid claims. The company’s stock price fell more than 12 percent July 31, the day after its second quarter earnings report.

Private Equity Firm Signals Interest In Devices With K2M Investment

Welsh, Carson, Anderson & Stowe, a long-time investor in health care services companies, signaled its intent to invest more deeply in the device sector with the acquisition of a majority position in spinal company K2M

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts